212 related articles for article (PubMed ID: 30605885)
1. Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.
Lu X; Yang H; Li Q; Chen Y; Li Q; Zhou Y; Feng F; Liu W; Guo Q; Sun H
Bioorg Chem; 2019 Apr; 85():117-127. PubMed ID: 30605885
[TBL] [Abstract][Full Text] [Related]
2. Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.
Yang H; Du C; Li Q; Chen T; Lu X; Li Q; Feng F; Chen Y; Liu W; Sun H
Bioorg Chem; 2019 Nov; 92():103294. PubMed ID: 31557623
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
[TBL] [Abstract][Full Text] [Related]
5. Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.
Lu T; Liu Y; Liu Y; Chen H; Han C; Feng X; Zhou H; Li Y
Future Med Chem; 2021 May; 13(9):769-784. PubMed ID: 33759552
[No Abstract] [Full Text] [Related]
6. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation.
Jiang CS; Ge YX; Cheng ZQ; Wang YY; Tao HR; Zhu K; Zhang H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31311169
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening.
Xing S; Chen Y; Xiong B; Lu W; Li Q; Wang Y; Jiao M; Feng F; Chen Y; Liu W; Sun H
Int J Biol Macromol; 2021 Jan; 166():1352-1364. PubMed ID: 33161083
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds.
Zhou S; Yuan Y; Zheng F; Zhan CG
Chem Biol Interact; 2019 Aug; 308():372-376. PubMed ID: 31152736
[TBL] [Abstract][Full Text] [Related]
10. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
[TBL] [Abstract][Full Text] [Related]
11. Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening.
Miles JA; Kapure JS; Deora GS; Courageux C; Igert A; Dias J; McGeary RP; Brazzolotto X; Ross BP
Bioorg Med Chem Lett; 2020 Dec; 30(24):127609. PubMed ID: 33039562
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening.
Williams A; Zhou S; Zhan CG
Bioorg Med Chem Lett; 2019 Dec; 29(24):126754. PubMed ID: 31708262
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
Jiang Y; Gao H
Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
[TBL] [Abstract][Full Text] [Related]
15. Discovery, Structure-Based Modification,
Lu X; Li Y; Guan Q; Yang H; Liu Y; Du C; Wang L; Wang Q; Pei Y; Wu L; Sun H; Chen Y
ACS Chem Neurosci; 2024 Mar; 15(6):1135-1156. PubMed ID: 38453668
[TBL] [Abstract][Full Text] [Related]
16. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.
Karlsson D; Fallarero A; Brunhofer G; Guzik P; Prinz M; Holzgrabe U; Erker T; Vuorela P
Eur J Pharm Sci; 2012 Jan; 45(1-2):169-83. PubMed ID: 22108346
[TBL] [Abstract][Full Text] [Related]
19. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
